iTolerance

iTolerance is a privately held regenerative medicine company enabling tissue, organoid or cell therapy without the need for life-long immunosuppression.

08/28/2026

At iTolerance, we're advancing data-driven regenerative medicine with the goal of enabling tissue, organoid and cell therapies without the need for lifelong immunosuppression.

08/17/2026

8.75 million people worldwide live with Type 1 Diabetes, yet many continue to face significant challenges despite insulin therapy.

iTolerance is advancing innovative approaches with the goal of transforming treatment.

08/07/2026

Be part of the journey.

Subscribe to iTolerance's email alerts for the latest updates as we work to advance innovative therapies for patients with type 1 diabetes.

Sign up: https://bit.ly/3PYFAqw

07/29/2026

An estimated 100K–135K people live with brittle Type 1 Diabetes, a severe form of the disease marked by dangerous blood sugar swings that can lead to seizures, coma, heart attacks and even death.

The unmet need remains significant.

07/22/2026

Be the first to hear what’s next at iTolerance.

Subscribe for email alerts and stay informed on the latest milestones, scientific progress and company developments.

Sign up: https://bit.ly/3PYFAqw

07/13/2026

At iTolerance, our values guide everything we do, from integrity and accountability to respect and teamwork.

Together, we are committed to advancing innovation while working to improve patients’ lives.

07/04/2026

Today, we celebrate 250 years of American independence and the freedoms that unite us.
From all of us at iTolerance, we wish you a safe, happy and meaningful Fourth of July.

06/22/2026

Get the latest updates from iTolerance delivered directly to your inbox.
Sign up for email alerts to stay informed on company news, research progress and updates.
https://bit.ly/3PYFAqw

06/15/2026

Even with insulin treatment, there remains a significant unmet need in Type 1 Diabetes.
Approximately 1.6 million adults over the age of 20 in the U.S. are living with T1D. We are working to improve these numbers.

06/05/2026

Innovation. Expertise. Breakthroughs.
iTolerance is a patient-first, data-driven regenerative medicine company focused on developing potential cures that improve the lives of people living with chronic conditions.

Address

1951 NW 7th Avenue
Miami, FL
33136

Website

http://www.itolerance.com/

Alerts

Be the first to know and let us send you an email when iTolerance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to iTolerance:

Featured

Christina Archer Consulting

Want your business to be the top-listed Business in Miami?